In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents

Tahereh Shokohi; Zainab Bandalizadeh; Mohmmad Taghi Hedayati; Sabah Mayahi

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents

Author(s):

Tahereh Shokohi^1,*,

Zainab Bandalizadeh²,

Mohmmad Taghi Hedayati²,

Sabah Mayahi²

1Deptartment of Medical Mycology and Parasitology, Sari Medical School and Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Shokohi.tahereh@gmail.com, Iran

2Deptartment of Medical Mycology and Parasitology, Sari Medical School, Mazandaran University of Medical Sciences, Iran

Jundishapur Journal of Microbiology:Vol. 4, issue Suppl; 19-26

Article type:Research Article

How to Cite:Tahereh ShokohiZainab BandalizadehMohmmad Taghi HedayatiSabah MayahiIn vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents.Jundishapur J Microbiol.4(Suppl):19-26.

Abstract

Introduction and objective: Oropharyngeal candidiasis is a relatively common mycotic infection in cancer patients. In vitro susceptibility of oropharyngeal Candida isolates can be useful in selecting the appropriate treatment for the best therapeutic outcome. The aim of this study was to evaluate the in vitro antifungal activity of Candida species against antifungal agents.

Material and methods: In vitro activities of four antifungals were detected in 69 Candida isolates recovered from cancer patients in four university hospitals using the microdilution method described in the CLSI M27-A3 guideline.

Result: Only 12(17.4%) of Candida isolate were resistant to antifungal agents. Three isolates (4.4% included C. albicans, C. glabrata, C. tropicalis, and C. pelliculosa) were resistant to amphotericin B, 5(7.2% included two C. albicans, two C. glabrata, and one C. kefyr) were itraconazole resistant. Two (2.9% include one C. albicans and one C. glabrata) were fluconazole resistant. Caspofungin resistance was detected in two C. infanticola strains which were reported as a clinical isolate for the first time. All Candida isolates (n=69) taken together gave minimum inhibitory concentration (MIC₉₀)value for amphotericin B, fluconazole, itraconazole and caspofungin of 1, 0.25, 32 and 0.25μg/ml, respectively. In total, 18.7% of C. glabrata and 7.8% of C. albicans isolates were fully resistant to both itraconazole and fluconazole.

Conclusion: Caspofungin had activity against oropharyngeal non- albicans Candida species isolates, particularly against those with reduced susceptibility to amphotericin B, fluconazole and itraconazole.

Keywords

Antifungals

In vitro susceptibility

Candida species

Oropharyngeal candidiasis

Full Text

Full text is available in PDF

comments